Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Imaging of bioluminescent LNCaP-luc-M6 tumors: a new animal model for the study of metastatic human prostate cancer.

The Prostate - 15 May 2004

Scatena Caroline D, Hepner Mischa A, Oei Yoko A, Dusich Joan M, Yu Shang-Fan, Purchio Tony, Contag Pamela R, Jenkins Darlene E

Abstract excerpt

BACKGROUND: Animal experiments examining hormone-sensitive metastatic prostate cancer using the human LNCaP cell line have been limited to endpoint analyses. To permit longitudinal studies, we generated a luciferase-expressing cell line and used bioluminescent imaging (BLI) to non-invasively monitor the in vivo growth of primary LNCaP tumors and metastasis. METHODS: LNCaP.FGC cells were transfected to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Luciferases
Share to Luminescent Measurements

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mice, SCID

Share to Neoplasm Metastasis

Share to Plasmids

Share to Prostatic Neoplasms

Share to Transplantation, Heterologous

Share to Tumor Cells, Cultured

Source

Identifiers

PMID: 15042605
DOI: 10.1002/pros.20003

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Imaging of bioluminescent LNCaP-luc-M6 tumors: a new animal model for the study of metastatic human prostate cancer.PMID 15042605Read ↗

Establishment of An Orthotopic Prostate Cancer Xenograft Mouse Model Using Microscope-Guided Orthotopic Injection of LNCaP Cells Into The Dorsal Lobe of The Mouse ProstateSemantic proximity Read ↗

LuCaP 35: a new model of prostate cancer progression to androgen independence.Semantic proximity Read ↗

<p class="MsoNormal" style="margin-bottom: 12.0pt; text-align: left; mso-line-height-alt: 14.0pt; layout-grid-mode: char; mso-layout-grid-align: none;" align="left">Evaluation of <sup>177</sup>Lu-PSMA-617 Based Targeted Radioligand Therapy with X-Ray Stimulated PSMA Relocation in the <em>PiggyBac</em> Reporter Gene Engineered Orthotopic Prostate Tumor ModelSemantic proximity Read ↗

Brief report: a bioassay to identify primary human prostate cancer repopulating cells.Semantic proximity Read ↗

Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice.Semantic proximity Read ↗

Identification of genes regulating migration and invasion using a new model of metastatic prostate cancerSemantic proximity Read ↗

Interleukin-6 promotes androgen-independent growth in LNCaP human prostate cancer cells.Semantic proximity Read ↗

Selection of cell lines with enhanced invasive phenotype from xenografts of the human prostate cancer cell line WPE1-NB26.Semantic proximity Read ↗

STAT3 mediates IL-6-induced growth inhibition in the human prostate cancer cell line LNCaP.Semantic proximity Read ↗

Pharmacologic suppression of JAK1/2 by JAK1/2 inhibitor AZD1480 potently inhibits IL-6-induced experimental prostate cancer metastases formation.Semantic proximity Read ↗

Abl kinase deficiency promotes AKT pathway activation and prostate cancer progression and metastasisSemantic proximity Read ↗

Establishment and characterization of three androgen-independent, metastatic carcinoma cell lines from 3,2'-dimethyl-4-aminobiphenyl-induced prostatic tumors in F344 rats.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.